{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:21:12Z","timestamp":1783027272456,"version":"3.54.6"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cancer Policy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jcpo.2026.100739","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:45:53Z","timestamp":1776177953000},"page":"100739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Analysing the suitability of tools used to assess cost-effectiveness of external beam radiation therapy \u2013 A scoping review"],"prefix":"10.1016","volume":"48","author":[{"given":"Taimia","family":"Alkanzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6510-1633","authenticated-orcid":false,"given":"Michelle","family":"Leech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcpo.2026.100739_bib1","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S1470-2045(19)30794-6","article-title":"How public health services pay for radiotherapy in Europe: an ESTRO-HERO analysis of reimbursement","volume":"21","author":"Lievens","year":"2020","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.jcpo.2026.100739_bib2","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun","year":"2015","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib3","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/ajco.13310","article-title":"Experiences of barriers and facilitators to establishing and sustaining radiotherapy services in low-and middle-income countries: a qualitative study","volume":"16","author":"Donkor","year":"2020","journal-title":"Asia-Pac. J. Clin. Oncol."},{"issue":"1116","key":"10.1016\/j.jcpo.2026.100739_bib4","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200247","article-title":"Heavy charged particle beam therapy and related new radiotherapy technologies: The clinical potential, physics and technical developments required to deliver benefit for patients with cancer","volume":"93","author":"Kirkby","year":"2020","journal-title":"Br. J. Radiol."},{"issue":"5","key":"10.1016\/j.jcpo.2026.100739_bib5","article-title":"Implementation of magnetic resonance imaging-guided radiation therapy in routine care: opportunities and challenges in the United States","volume":"7","author":"Hehakaya","year":"2022","journal-title":"Adv. Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clon.2016.12.004","article-title":"Global access to radiotherapy in low- and middle-income countries","volume":"29","author":"Abdel-Wahab","year":"2017","journal-title":"Clin. Oncol."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.clon.2016.10.009","article-title":"Innovations in radiotherapy technology","volume":"29","author":"Feain","year":"2017","journal-title":"Clin. Oncol."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.radonc.2018.06.026","article-title":"Impact of radiotherapy underutilisation measured by survival shortfall, years of potential life lost and disability-adjusted life years lost in New South Wales, Australia","volume":"129","author":"Batumalai","year":"2018","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib9","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/j.clon.2011.06.010","article-title":"Mapping use of radiotherapy for patients with non-small cell lung cancer in the Netherlands between 1997 and 2008","volume":"24","author":"Koning","year":"2012","journal-title":"Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jcpo.2026.100739_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2015.04.018","article-title":"The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis","volume":"116","author":"Borras","year":"2015","journal-title":"Radiother. Oncol."},{"issue":"8","key":"10.1016\/j.jcpo.2026.100739_bib11","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","article-title":"Global cancer transitions according to the Human Development Index (2008\u20132030): a population-based study","volume":"13","author":"Bray","year":"2012","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jmrs.273","article-title":"Cost-containment in hypofractionated radiation therapy: a literature review","volume":"65","author":"Hunter","year":"2018","journal-title":"J. Med. Radiat. Sci."},{"issue":"1","key":"10.1016\/j.jcpo.2026.100739_bib13","first-page":"35","article-title":"Trends and issues in oncology costs","volume":"14","author":"Scalo","year":"2014","journal-title":"Expert Rev. Pharm. Outcomes Res."},{"issue":"4","key":"10.1016\/j.jcpo.2026.100739_bib14","article-title":"Disparities in the utilization of radiation therapy for prostate cancer in the united states: a comprehensive review","volume":"7","author":"Gardner","year":"2022","journal-title":"Adv. Radiat. Oncol."},{"issue":"7","key":"10.1016\/j.jcpo.2026.100739_bib15","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.4251\/wjgo.v16.i7.2925","article-title":"Disparities in the diagnosis and treatment of colorectal cancer among patients with disabilities","volume":"16","author":"Kim","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100739_bib16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.radonc.2016.12.002","article-title":"Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis","volume":"121","author":"Defourny","year":"2016","journal-title":"Radio. Oncol."},{"issue":"6","key":"10.1016\/j.jcpo.2026.100739_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7785\/tcrt.2012.500344","article-title":"Robotic radiosurgery for the treatment of 1\u20133 brain metastases: a pragmatic application of cost-benefit analysis using willingness-to-pay","volume":"12","author":"Greenspoon","year":"2013","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.jcpo.2026.100739_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fpubh.2015.00164","article-title":"Economic evaluation enhances public health decision making","volume":"3","author":"Rabarison","year":"2015","journal-title":"Front. Public Health"},{"issue":"4","key":"10.1016\/j.jcpo.2026.100739_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/1754-9485.12334","article-title":"Barriers to radiotherapy utilisation in N ew S outh W ales A ustralia: health professionals' perceptions of impacting factors","volume":"59","author":"Sundaresan","year":"2015","journal-title":"J. Med. Imaging Radiat. Oncol."},{"key":"10.1016\/j.jcpo.2026.100739_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejca.2017.07.011","article-title":"Radiotherapy access in Belgium: How far are we from evidence-based utilisation?","volume":"84","author":"Lievens","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jcpo.2026.100739_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2016.10.042","article-title":"Promoting the appropriate use of advanced radiation technologies in oncology: summary of a national cancer policy forum workshop","author":"Smith","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"26","key":"10.1016\/j.jcpo.2026.100739_bib22","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1200\/JCO.2014.55.1150","article-title":"Value: a framework for radiation oncology","volume":"32","author":"Teckie","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.jcpo.2026.100739_bib23","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ijrobp.2015.12.359","article-title":"Evaluation of health economics in radiation oncology: a systematic review","volume":"94","author":"Nguyen","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.radonc.2017.08.034","article-title":"A systematic review of health economic evaluation in adjuvant breast radiotherapy: quality counted by numbers","volume":"125","author":"Monten","year":"2017","journal-title":"Radiother. Oncol."},{"issue":"5","key":"10.1016\/j.jcpo.2026.100739_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.862","article-title":"A framework for economic evaluation of therapeutic drug monitoring-guided dosing in oncology","volume":"9","author":"Erku","year":"2021","journal-title":"Pharm. Res. Perspect."},{"key":"10.1016\/j.jcpo.2026.100739_bib26","doi-asserted-by":"crossref","unstructured":"S.J. Senanayake, Q. Xia, D. Brain, S.M. McPhail, S. Kularatna, W. Parsonage, , 2023, Health service resource use and costs of interventional oncology procedures: a micro-costing analysis.","DOI":"10.31219\/osf.io\/4gpb6"},{"issue":"7","key":"10.1016\/j.jcpo.2026.100739_bib27","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/lary.27544","article-title":"Cost comparison of treatment for oropharyngeal carcinoma","volume":"129","author":"Tam","year":"2019","journal-title":"Laryngoscope"},{"issue":"8","key":"10.1016\/j.jcpo.2026.100739_bib28","doi-asserted-by":"crossref","DOI":"10.1200\/GO.21.00374","article-title":"Adopting health economic research in radiation oncology: a perspective from low-or middle-income countries","author":"Sinha","year":"2022","journal-title":"JCO Glob. Oncol."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100739_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.radonc.2004.02.021","article-title":"Multinational assessment of some operational costs of teletherapy","volume":"71","author":"Van Der Giessen","year":"2004","journal-title":"Radiother. Oncol."},{"issue":"9","key":"10.1016\/j.jcpo.2026.100739_bib30","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3109\/0284186X.2015.1066932","article-title":"Cost calculation: a necessary step towards widespread adoption of advanced radiotherapy technology","volume":"54","author":"Lievens","year":"2015","journal-title":"Acta Oncol."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100739_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1071\/AH22293","article-title":"Higher fees and out-of-pocket costs in radiotherapy point to a need for funding reform","volume":"47","author":"van Gool","year":"2023","journal-title":"Aust. Health Rev."},{"issue":"10","key":"10.1016\/j.jcpo.2026.100739_bib32","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/13696998.2019.1639186","article-title":"Willingness to pay for QALY: perspectives and contexts in Japan","volume":"22","author":"Igarashi","year":"2019","journal-title":"J. Med. Econ."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100739_bib33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/0272989X0002000310","article-title":"Willingness to pay for a quality-adjusted life year: in search of a standard","volume":"20","author":"Hirth","year":"2000","journal-title":"Med. Decis. Mak."},{"issue":"9","key":"10.1016\/j.jcpo.2026.100739_bib34","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness\u2014the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jcpo.2026.100739_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.2249","article-title":"Cost-effectiveness of short-course radiation therapy vs long-course chemoradiation for locally advanced rectal cancer","volume":"2","author":"Raldow","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/jnci\/djp472","article-title":"When is cancer care cost-effective? a systematic overview of cost-utility analyses in oncology","volume":"102","author":"Greenberg","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.jcpo.2026.100739_bib37","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s40273-024-01413-8","article-title":"Systematic review of economic evaluations of systemic treatments for advanced and metastatic gastric cancer","volume":"42","author":"Sharma","year":"2024","journal-title":"PharmacoEconomics"},{"issue":"8","key":"10.1016\/j.jcpo.2026.100739_bib38","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s40273-023-01279-2","article-title":"A systematic review of the cost-effectiveness analyses of Anaplastic lymphoma kinase (ALK) inhibitors in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)","volume":"41","author":"Chayab","year":"2023","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jcpo.2026.100739_bib39","first-page":"19","article-title":"A systematic review of health economic evaluations of proton beam therapy for adult cancer: appraising methodology and quality","volume":"20","author":"Jones","year":"2020","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"17","key":"10.1016\/j.jcpo.2026.100739_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191710800","article-title":"Economic evaluations of magnetic resonance image-guided radiotherapy (MRIgRT): a systematic review","volume":"19","author":"Castelluccia","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jcpo.2026.100739_bib41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40258-014-0115-8","article-title":"What is the quality of economic evaluations of non-drug therapies? A systematic review and critical appraisal of economic evaluations of radiotherapy for cancer","volume":"12","author":"Barbieri","year":"2014","journal-title":"Appl. Health Econ. Health Policy"},{"issue":"10","key":"10.1016\/j.jcpo.2026.100739_bib42","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid. Synth."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100739_bib43","first-page":"170","article-title":"Conducting systematic reviews of economic evaluations","volume":"13","author":"Gomersall","year":"2015","journal-title":"JBI Evid. Implement."},{"issue":"7","key":"10.1016\/j.jcpo.2026.100739_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jcpo.2026.100739_bib45","doi-asserted-by":"crossref","unstructured":"Drummond M., Sculpher M., Torrance G., O\u2019Brien B., Stoddart G. Methods for the economic evaluation of health care programmes. Third edition ed: Oxford University Press; 2005.","DOI":"10.1093\/oso\/9780198529446.001.0001"},{"key":"10.1016\/j.jcpo.2026.100739_bib46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00019053-200826050-00003","article-title":"Economic evaluation of interventions to treat opiate dependence: a review of the evidence","volume":"26","author":"Doran","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"10.1016\/j.jcpo.2026.100739_bib47","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clon.2012.05.004","article-title":"Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer","volume":"24","author":"Yong","year":"2012","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.jcpo.2026.100739_bib48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.breast.2021.04.002","article-title":"Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer","volume":"58","author":"Yang","year":"2021","journal-title":"Breast"},{"issue":"3 March","key":"10.1016\/j.jcpo.2026.100739_bib49","article-title":"Cost-effectiveness analysis of radiotherapy techniques for whole breast irradiation","volume":"16","author":"Xie","year":"2021","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.jcpo.2026.100739_bib50","article-title":"Cost-effectiveness analysis comparing intensity-modulated radiotherapy with conformational radiotherapy (3D-RT) for prostate cancer in the Brazilian health system","volume":"67","author":"Viani","year":"2021","journal-title":"Rev. da Assoc. Med. Bras."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.radonc.2015.01.005","article-title":"Spacers in radiotherapy treatment of prostate cancer: is reduction of toxicity cost-effective?","volume":"114","author":"Vanneste","year":"2015","journal-title":"Radio. Oncol."},{"issue":"1","key":"10.1016\/j.jcpo.2026.100739_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semradonc.2013.08.002","article-title":"Decision analysis and cost-effectiveness analysis for comparative effectiveness research-a primer","volume":"24","author":"Sher","year":"2014","journal-title":"Semin. Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib53","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ijrobp.2018.09.021","article-title":"Cost and cost-effectiveness of image guided partial breast irradiation in comparison to hypofractionated whole breast irradiation","volume":"103","author":"Shah","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1114","key":"10.1016\/j.jcpo.2026.100739_bib54","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200028","article-title":"Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer","volume":"93","author":"Schumacher","year":"2020","journal-title":"Br. J. Radiol."},{"issue":"23","key":"10.1016\/j.jcpo.2026.100739_bib55","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1002\/cncr.29642","article-title":"Cost-effectiveness analysis of neurocognitive-sparing treatments for brain metastases","volume":"121","author":"Savitz","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jcpo.2026.100739_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s12962-024-00577-6","article-title":"Cost-effectiveness of proton beam therapy vs. conventional radiotherapy for patients with brain tumors in Sweden: results from a non-randomized prospective multicenter study","volume":"22","author":"Sampaio","year":"2024","journal-title":"Cost. Eff. Resour. Alloc."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100739_bib57","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ijrobp.2016.02.005","article-title":"Cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for preoperative treatment of extremity soft tissue sarcomas","volume":"95","author":"Richard","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100739_bib58","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.radonc.2017.01.005","article-title":"Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer","volume":"122","author":"Qu","year":"2017","journal-title":"Radiother. Oncol."},{"issue":"4","key":"10.1016\/j.jcpo.2026.100739_bib59","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1590\/1806-9282.64.04.318","article-title":"Intensity-modulated radiation therapy (IMRT) versus 3-dimensional conformal radiation therapy (3D-CRT) for head and neck cancer: Cost-effectiveness analysis","volume":"64","author":"Marta","year":"2018","journal-title":"Rev. da Assoc. Med. Bras."},{"issue":"1","key":"10.1016\/j.jcpo.2026.100739_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2016.02.031","article-title":"Establishing cost-effective allocation of proton therapy for breast irradiation","volume":"95","author":"Mailhot Vega","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jcpo.2026.100739_bib61","article-title":"Cost-effectiveness of using protons for breast irradiation aiming at minimizing cardiotoxicity: a risk-stratification analysis","volume":"9","author":"Li","year":"2022","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib62","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1016\/j.prro.2018.10.003","article-title":"Evaluating the cost-effectiveness of hydrogel rectal spacer in prostate cancer radiation therapy","volume":"9","author":"Levy","year":"2019","journal-title":"Pract. Radiat. Oncol."},{"issue":"43","key":"10.1016\/j.jcpo.2026.100739_bib63","doi-asserted-by":"crossref","first-page":"75568","DOI":"10.18632\/oncotarget.17369","article-title":"Cost-utility of stereotactic radiation therapy versus proton beam therapy for inoperable advanced hepatocellular carcinoma","volume":"8","author":"Leung","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcpo.2026.100739_bib64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3171\/2016.7.GKS161499","article-title":"Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases","volume":"125","author":"Lester-Coll","year":"2016","journal-title":"J. Neurosurg."},{"issue":"10","key":"10.1016\/j.jcpo.2026.100739_bib65","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.clon.2017.05.001","article-title":"Cost-effectiveness Analysis of Stereotactic Radiosurgery Alone Versus Stereotactic Radiosurgery with Upfront Whole Brain Radiation Therapy for Brain Metastases","volume":"29","author":"Kim","year":"2017","journal-title":"Clin. Oncol."},{"issue":"4","key":"10.1016\/j.jcpo.2026.100739_bib66","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ijrobp.2023.12.052","article-title":"An Economic Analysis of SC24 in Canada: A Randomized Study of SBRT Compared With Conventional Palliative RT for Spinal Metastases","volume":"119","author":"Kerba","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"10.1016\/j.jcpo.2026.100739_bib67","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/1754-9485.13311","article-title":"Cost-effectiveness analysis of hydrogel spacer for rectal toxicity reduction in prostate external beam radiotherapy","volume":"65","author":"Jones","year":"2021","journal-title":"J. Med. Imaging Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib68","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10549-022-06802-1","article-title":"Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis","volume":"197","author":"Glynn","year":"2023","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.jcpo.2026.100739_bib69","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0266462320000677","article-title":"Cost-effectiveness of treating head and neck cancer using intensity-modulated radiation therapy: Implications for cancer control program in India","volume":"36","author":"Chauhan","year":"2020","journal-title":"Int. J. Technol. Assess. Health Care"},{"issue":"4","key":"10.1016\/j.jcpo.2026.100739_bib70","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaccao.2024.04.009","article-title":"Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy: A Balance Between Side Effects and Costs","volume":"6","author":"Busschaert","year":"2024","journal-title":"JACC CardioOncology"},{"issue":"4","key":"10.1016\/j.jcpo.2026.100739_bib71","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s13246-019-00810-0","article-title":"Cost-effectiveness of proton therapy in treating base of skull chordoma","volume":"42","author":"Austin","year":"2019","journal-title":"Australas. Phys. Eng. Sci. Med."},{"issue":"1","key":"10.1016\/j.jcpo.2026.100739_bib72","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jmrs.416","article-title":"Individualised selection of left-sided breast cancer patients for proton therapy based on cost-effectiveness","volume":"68","author":"Austin","year":"2021","journal-title":"J. Med Radiat. Sci."},{"key":"10.1016\/j.jcpo.2026.100739_bib73","article-title":"Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system","volume":"14","author":"Arruda","year":"2022","journal-title":"Lancet Reg. Health - Am."},{"key":"10.1016\/j.jcpo.2026.100739_bib74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fonc.2012.00081","article-title":"Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer","volume":"2","author":"Parthan","year":"2012","journal-title":"Front Oncol."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib75","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10198-022-01467-5","article-title":"Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost-utility analysis alongside a randomized HYPO-RT-PC trial","volume":"24","author":"Sun","year":"2023","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.jcpo.2026.100739_bib76","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.radonc.2022.06.014","article-title":"Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial \u2013 PROFIT","volume":"173","author":"Zhou","year":"2022","journal-title":"Radiother. Oncol."},{"issue":"8","key":"10.1016\/j.jcpo.2026.100739_bib77","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.21873\/anticanres.12797","article-title":"Cost-effectiveness of carbon ion radiation therapy for skull base chordoma utilizing long-term (10-year) outcome data","volume":"38","author":"Sprave","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jcpo.2026.100739_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110116","article-title":"Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial","volume":"193","author":"Perrier","year":"2024","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib79","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/cas.15216","article-title":"Cost-effectiveness of carbon-ion radiotherapy versus stereotactic body radiotherapy for non-small-cell lung cancer","volume":"113","author":"Okazaki","year":"2022","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100739_bib80","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1200\/JOP.2013.001206","article-title":"Cost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage i non-small-cell lung cancer","volume":"10","author":"Mitera","year":"2014","journal-title":"J. Oncol. Pract."},{"issue":"1","key":"10.1016\/j.jcpo.2026.100739_bib81","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-021-01745-1","article-title":"Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer","volume":"16","author":"Brodin","year":"2021","journal-title":"Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100739_bib82","first-page":"215","article-title":"Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer","volume":"37","author":"Sher","year":"2014","journal-title":"Am. J. Clin. Oncol. Cancer Clin. Trials"},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib83","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mbs.2009.05.005","article-title":"Bias in Markov models of disease","volume":"220","author":"Faissol","year":"2009","journal-title":"Math. Biosci."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib84","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0266462314000117","article-title":"Markov modeling and discrete event simulation in health care: a systematic comparison","volume":"30","author":"Standfield","year":"2014","journal-title":"Int. J. Technol. Assess. Health care"},{"key":"10.1016\/j.jcpo.2026.100739_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12911-019-0910-0","article-title":"Improving workflow control in radiotherapy using discrete-event simulation","volume":"19","author":"Vieira","year":"2019","journal-title":"BMC Med. Inform. Decis. Mak."},{"issue":"1039","key":"10.1016\/j.jcpo.2026.100739_bib86","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130742","article-title":"Audit of the job satisfaction levels of the UK radiography and physics workforce in UK radiotherapy centres 2012","volume":"87","author":"Hutton","year":"2014","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.jcpo.2026.100739_bib87","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40273-015-0309-4","article-title":"Dealing with time in health economic evaluation: methodological issues and recommendations for practice","volume":"33","author":"O\u2019Mahony","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"10.1016\/j.jcpo.2026.100739_bib88","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.3390\/ijms24076272","article-title":"Radiation treatment mechanisms of cardiotoxicity: a systematic review","volume":"24","author":"Siaravas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jcpo.2026.100739_bib89","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2014.10.004","article-title":"Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients","volume":"114","author":"Grantzau","year":"2015","journal-title":"Radiother. Oncol."},{"issue":"7","key":"10.1016\/j.jcpo.2026.100739_bib90","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/1878-0261.12690","article-title":"Provision and use of radiotherapy in Europe","volume":"14","author":"Lievens","year":"2020","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.jcpo.2026.100739_bib91","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.3390\/curroncol29050270","article-title":"Using a weekly patient-reported outcome questionnaire to track acute toxicity in patients undergoing pelvic radiotherapy for gynecologic cancers","volume":"29","author":"Chan","year":"2022","journal-title":"Curr. Oncol."},{"issue":"8","key":"10.1016\/j.jcpo.2026.100739_bib92","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1177\/0272989X16656165","article-title":"Changing cycle lengths in state-transition models: challenges and solutions","volume":"36","author":"Chhatwal","year":"2016","journal-title":"Med. Decis. Mak."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100739_bib93","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang","year":"2019","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.jcpo.2026.100739_bib94","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s10198-022-01445-x","article-title":"A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots","volume":"23","author":"Khorasani","year":"2022","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.jcpo.2026.100739_bib95","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40273-018-0672-z","article-title":"Discounting in economic evaluations","volume":"36","author":"Attema","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jcpo.2026.100739_bib96","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vhri.2020.05.004","article-title":"Out-of-pocket costs and importance of nonmedical and indirect costs of inpatients","volume":"24","author":"Sabermahani","year":"2021","journal-title":"Value Health Reg. Issues"},{"issue":"7","key":"10.1016\/j.jcpo.2026.100739_bib97","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/1878-0261.12712","article-title":"Role of radiation oncology in modern multidisciplinary cancer treatment","volume":"14","author":"Valentini","year":"2020","journal-title":"Mol. Oncol."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib98","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2014.08.029","article-title":"Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey","volume":"112","author":"Grau","year":"2014","journal-title":"Radiother. Oncol."},{"issue":"12","key":"10.1016\/j.jcpo.2026.100739_bib99","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00066-022-01936-z","article-title":"Financial toxicity in cancer patients treated with radiotherapy in Germany\u2014a cross-sectional study","volume":"198","author":"Fabian","year":"2022","journal-title":"Strahlenther. und Onkol."},{"issue":"5","key":"10.1016\/j.jcpo.2026.100739_bib100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10198-022-01501-6","article-title":"Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries","volume":"24","author":"Mokri","year":"2023","journal-title":"Eur. J. Health Econ."},{"issue":"4","key":"10.1016\/j.jcpo.2026.100739_bib101","doi-asserted-by":"crossref","DOI":"10.3747\/co.23.3073","article-title":"Radiation costing methods: a systematic review","volume":"23","author":"Rahman","year":"2016","journal-title":"Curr. Oncol."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib102","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijrobp.2017.09.041","article-title":"Systematic review of normal tissue complication models relevant to standard fractionation radiation therapy of the head and neck region published after the QUANTEC reports","volume":"100","author":"Brodin","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100739_bib103","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijrobp.2015.02.021","article-title":"Systematic review of radiation therapy toxicity reporting in randomized controlled trials of rectal cancer: a comparison of patient-reported outcomes and clinician toxicity reporting","volume":"92","author":"Gilbert","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.jcpo.2026.100739_bib104","first-page":"64","article-title":"Impact of radiotherapy-related late toxicities of skin and soft tissue in the neck on quality of life in head and neck cancer patients: a multi-institutional observational study in Japan","volume":"33","author":"Higashino","year":"2025","journal-title":"Support. Care Cancer"},{"issue":"3","key":"10.1016\/j.jcpo.2026.100739_bib105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.adro.2017.04.002","article-title":"Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: a large single-institutional cohort study","volume":"2","author":"Shi","year":"2017","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.jcpo.2026.100739_bib106","first-page":"3105","article-title":"Acute skin toxicity-related, out-of-pocket expenses in patients with breast cancer treated with external beam radiotherapy: a descriptive, exploratory study","volume":"20","author":"Schnur","year":"2012","journal-title":"Support. Care Cancer"},{"issue":"8","key":"10.1016\/j.jcpo.2026.100739_bib107","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1524-4733.2009.00581.x","article-title":"International comparisons in valuing EQ-5D health states: a review and analysis","volume":"12","author":"Norman","year":"2009","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jcpo.2026.100739_bib108","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1038\/s41598-022-07528-2","article-title":"Understanding health problems in people with extremely low health-related quality of life in Korea","volume":"12","author":"Tran","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jcpo.2026.100739_bib109","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s11136-015-1203-4","article-title":"Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study","volume":"25","author":"Sayah","year":"2016","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.jcpo.2026.100739_bib110","unstructured":"NICE) NIfCE. Guide to the methods of technology appraisal. 2013."},{"key":"10.1016\/j.jcpo.2026.100739_bib111","unstructured":"van Busschbach J., MC E., van Hout B. QALY en kwaliteit-van-leven-metingen Herziene versie 2024. 2024."},{"issue":"4","key":"10.1016\/j.jcpo.2026.100739_bib112","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/0269216316689652","article-title":"The use of quality-adjusted life years in cost-effectiveness analyses in palliative care: mapping the debate through an integrative review","volume":"31","author":"Wichmann","year":"2017","journal-title":"Palliat. Med."},{"issue":"8","key":"10.1016\/j.jcpo.2026.100739_bib113","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2165\/11588250-000000000-00000","article-title":"Using QALYs in cancer: a review of the methodological limitations","volume":"29","author":"Garau","year":"2011","journal-title":"Pharmacoeconomics"},{"issue":"29","key":"10.1016\/j.jcpo.2026.100739_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13290","article-title":"Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making","volume":"13","author":"Andronis","year":"2009","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.jcpo.2026.100739_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40273-020-00979-3","article-title":"The application and implications of novel deterministic sensitivity analysis methods","volume":"39","author":"Vreman","year":"2021","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"10.1016\/j.jcpo.2026.100739_bib116","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1200\/JCO.2015.62.9105","article-title":"Cost-effectiveness of pertuzumab in human epidermal growth factor receptor 2\u2013positive metastatic breast cancer","volume":"34","author":"Durkee","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jcpo.2026.100739_bib117","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s40273-018-0697-3","article-title":"Probabilistic sensitivity analysis in cost-effectiveness models: determining model convergence in cohort models","volume":"36","author":"Hatswell","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.jcpo.2026.100739_bib118","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/13696998.2019.1588737","article-title":"Cost-effectiveness analyses using real-world data: an overview of the literature","volume":"22","author":"Bowrin","year":"2019","journal-title":"J. Med. Econ."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100739_bib119","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11845-023-03494-4","article-title":"Palliative radiotherapy and the introduction of a Rapid Access Palliative Clinic in a national radiation oncology network","volume":"193","author":"O\u2019Leary","year":"2024","journal-title":"Irish J. Med. Sci."},{"issue":"4","key":"10.1016\/j.jcpo.2026.100739_bib120","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ijrobp.2018.03.009","article-title":"radiation therapy research: a global analysis 2001-2015","volume":"101","author":"Aggarwal","year":"2018","journal-title":"Int J. Radiat. Oncol. Biol. Phys."}],"container-title":["Journal of Cancer Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538326000408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538326000408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:48:38Z","timestamp":1783025318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213538326000408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":120,"alternative-id":["S2213538326000408"],"URL":"https:\/\/doi.org\/10.1016\/j.jcpo.2026.100739","relation":{},"ISSN":["2213-5383"],"issn-type":[{"value":"2213-5383","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysing the suitability of tools used to assess cost-effectiveness of external beam radiation therapy \u2013 A scoping review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cancer Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcpo.2026.100739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100739"}}